Large Cap Biopharma Fights the “Undertow” With Gains for the Week…Update-3…caution…..
7/17/25.. 2.35P EDT...Calmer markets today with momentum coming back on selected SMID Biotechs: COGT, EYPT, MRUS, SLDB ,SUPG. XBI holding at $88 level but ARKG weaker and down 6% over five days. Large caps mixed with NVS and LLY weak. 7/15/25...caution on red tape today as all major biotech...
Small Cap Biotechs: A Huge Opportunity for Traders and Investors…UPDATE-2…tariff talk!
Update-2 ...7/11/25...Momentum eases on tariiff threat with Canada. President Trump said tariffs on Canadian goods will go up to 35% next month. The market was at new highs on Thursday and this apparently gave Trump more leeway to launch stronger messages to our North American "trade partners"....
Large Cap Biopharma Tracking and News: Maintain a HOLD…Update-2 … a good week for biopharma
Update-2 7/3/25...FIVE Day % winners: AMGN 6.85%, BIIB 4.9%, GILD 3.4%, MRK up 2.66%, PFE 4.7%,REGN 5.06%, VRTX 3.66%. BIOPHARMA OUTperformed many TECH ETFS: QQQ up 1.83%,, SOXX up 1.79%,XLK up 2.35%. BMY up 0.58%.LLY down 1.82%, NVS up 1.3%. NEWs : REGENERON bispecific antibody gets...
Large Cap Biopharma Winners YTD: Looking for Growth and Value in a Choppy Market..Update-3
Update-3 6/26 A good day overall with not much momentum in biotech.Will summarize the action on Friday.. Trading focus remains small cap biotechs to see if strong moves can hold....key indicators are ARKG and XBI. Its all about TECH and AI for now....
Biotech stocks Wobble a bit after a Grueling Week but Deals and Clinical News can Drive Stocks Higher…Update-3…FED on hold
6/18/25...FED on hold with economy ok but tariffs creating uncertainty-rates unchanged. Nice little rally in SMID biotechs with both ARKG and XBI holding. Modest gains in GH, LGND,NTRA, ROIV, RXRX, SDGR, SLDB, SUPN , TWST, TGX, VCYT, WVE. Optimism in biotechs could be a result of an IPO: Caris...